Sei Naito

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients

Sei Naito, Naoki Yamamoto, Tatsuya Takayama et al. · European Urology · 2009 · 194 citations

Medicine, Oncology, Pathology +12

Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma

Hideyuki Akaza, Tadashi Tsukamoto, Masaru Murai et al. · Japanese Journal of Clinical Oncology · 2007 · 152 citations

Medicine, Oncology, Pharmacology +15

A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety

Hirotsugu Uemura, Nozomi Shinohara, Takeshi Yuasa et al. · Japanese Journal of Clinical Oncology · 2009 · 138 citations · Full text

Medicine, Oncology, Pharmacology +15

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

Vladimir Bilim, Andrei V. Ougolkov, Kaori Yuuki et al. · British Journal of Cancer · 2009 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma

Yoshihiko Tomita, Nobuo Shinohara, Takeshi Yuasa et al. · Japanese Journal of Clinical Oncology · 2010 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17